Duke Team Says Sequencing May be Better than GWAS at Pinpointing Disease-Causing Variants | GenomeWeb

By Monica Heger

Sequencing may be better than genome-wide association studies at finding causal variants in common diseases, according to researchers from Duke University.

The researchers came to this conclusion after performing whole-genome sequencing studies on 29 individuals and finding that rare variants are significantly more likely than common ones to be functional.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.